Tuesday, 11 August 2026 · World
USD/EUR 0.8659 USD/GBP 0.7404 USD/JPY 159 USD/CNY 6.755 All rates →
RSS
EUROS The World Financial Report
Nº 31 Tuesday, 11 August 2026 · World Edition
LATEST
Markets

NovelMed Advances NM5072 for Multiple Ocular Disorders

News Ticker - markets.businessinsider.com · 2h ago
NovelMed Advances NM5072 for Multiple Ocular Disorders

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />Key Highlights <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Multi-indication precedent: Biogen’s approximately $5.6 billion acquisition of Apellis added EMPAVELI for PNH and SYFOVRE for GA, both of which contain pegcetacoplan.

Read the full story at News Ticker - markets.businessinsider.com →